Tuesday 28 January 2014

Tea and Health

The relationship between tea and health goes back into centuries. Scientists throughout the ages have commented on the beneficial effects of ‘tea’ on human health. The secret of healthy and long lives of the Chinese can be linked to green tea. Recent studies have claimed that green tea plays an important role in averting many types of cancer. The green tea comprises of polyphenol content which is an anti-oxidant. It relieves the body of many unhealthy toxins which can harm the human body. It amplifies the stamina of the body and reduces the armful fats. The doctor`s consultation should be taken before utilizing high intake of tea for disease prevention as excessive intake of tea can result into nutritional and other miscellaneous issues because of the strong binding activities of caffeine and polyphenols.


On the other hand, tea contains Oxalate. If it is consumed in high percentage, it increases the chances of kidney stone formation. A study of the year 2012 proposed that men who have more than seven cups of black tea have more chances of getting prostate cancer. The research was carried out on 6,016 men. Three hundred and eighteen people were diagnosed with cancer in the follow-up of the study. the 50% increased relative risk was based on the observation that 6.4% of those in the highest tea consumption group developed prostate cancer during the study period compared with 4.6% in the lowest consumption group (0-3 cups a day).


Bentham Science Publishers is a remarkable name in the STM Publishing Industry. It has 130 plus Online and Print Journals, 200 plus Open Access Journals and around 300 e-books. Some of their leading publications include Current Gene Therapy, Current Drug Metabolism, Current Molecular Medicine and Current Medicinal Chemistry. They have also journals based on “Current Alzheimer Research” and “Clinical Cancer Drugs.” These journals are an essential reading for all the clinicians and researchers working in these fields.

Thursday 23 January 2014

Bentham eBooks: Clinical Cancer Drugs:

Bentham Science Publishers is proud to announce its new journal, Clinical Cancer Drugs. It publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research


The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.
Bentham Science aims to publish eBooks in all major areas of technology, social sciences, medicine and humanities. Their eBooks provide professionals, corporate researchers, academicians, graduates and under-graduates globally with the most contemporary information in their subject areas of interest. Please click on the Clinical Cancer Drugs for details. The introductory issue is free!


Saturday 11 January 2014

Headache:

Headache is considered to be one of the most common conditions of pain in the head. The major symptoms of headache are eye-strain, dehydration, migraine, sinusitis and low blood sugar.
Headaches can also be a cause of many life threatening diseases like brain tumors, meningitis, encephalitis, acute blood pressure and cerebral aneurysms.
Uncomplicated headache can be treated with the help of painkillers like aspirin, paracetamol, ibuprofen or more suitable treatment. In serious cases of headaches, doctors recommend Computed Tomography (CT/CAT), scanning of the brain and MRI in some cases. Blood tests also play a vital role in the diagnosis of different types of headaches.

Bentham Science Publishers is a remarkable name in the publishing industry. It comprises of more than 100 subscription-based journals and eBooks including topics on drug discovery science, medicine and technology amongst others. CNS & Neurological Disorders - Drug Target which has an article named “Central Sensitisation Phenomena in Primary Headaches: Overview of a Preventive Therapeutic Approach”  by M. Ranieri. The article aims to review the factors concurrent with an increase in central sensitization, in view of the choice of preventive agents for primary headaches.